Ergo Science (Ergo Science) ROCE % : -2.44% (As of Sep. 2006)

View and export this data going back to . Start your Free Trial

What is Ergo Science ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ergo Science's annualized ROCE % for the quarter that ended in Sep. 2006 was -2.44%.

Ergo Science ROCE % Historical Data

The historical data trend for Ergo Science's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science ROCE % Chart

Ergo Science Annual Data

Trend

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

ROCE %

Get a 7-Day Free Trial

-9.84

-4.12

-11.78

1.91

-5.34

Ergo Science Quarterly Data
	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06
ROCE %	Get a 7-Day Free Trial															-13.03	-	-34.18	-22.56	-2.44

Ergo Science ROCE % Calculation

Ergo Science's annualized ROCE % for the fiscal year that ended in Dec. 2005 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2005 )		(A: Dec. 2004 )		(A: Dec. 2005 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2005 )		(A: Dec. 2004 )		(A: Dec. 2005 )
	=	-2.589	/	( ( (89.942 - 14.418)	+	(32.092 - 10.611) )	/ 2 )
	=	-2.589	/	( (75.524	+	21.481)	/ 2 )
	=	-2.589	/	48.5025
	=	-5.34 %

Ergo Science's ROCE % of for the quarter that ended in Sep. 2006 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2006 )		(Q: Jun. 2006 )		(Q: Sep. 2006 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2006 )		(Q: Jun. 2006 )		(Q: Sep. 2006 )
	=	-0.492	/	( ( (34.183 - 14.37)	+	(32.069 - 11.609) )	/ 2 )
	=	-0.492	/	( ( 19.813	+	20.46 )	/ 2 )
	=	-0.492	/	20.1365
	=	-2.44 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2006) EBIT data.

Ergo Science (GREY:ERGN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ergo Science ROCE % Related Terms

Thank you for viewing the detailed overview of Ergo Science's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ergo Science (Ergo Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223

Website

http://www.ergoscience.com

Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.

Executives

Citigroup Inc	director	388 GREENWICH STREET, NEW YORK NY 10013
Iticorp	director	399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp	director	ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co	director	336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd	director	399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines